Geneva Advisors’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
$943K Buy
19,104
+639
+3% +$31.5K 0.02% 372
2017
Q1
$802K Buy
+18,465
New +$802K 0.01% 401